ProShare Advisors’s Adicet Bio ACET Stock Holding History

ProShare Advisors’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-696	Closed	-$115K	–	2003
2021 Q2	$115K	Buy	+696	New	+$142K	﹤0.01%	2275
2019 Q4	–	Sell	-103	Closed	-$102K	–	1789
2019 Q3	$102K	Buy	103 +3	+3%	+$3.35K	﹤0.01%	1543
2019 Q2	$115K	Buy	100 +7	+8%	+$6.34K	﹤0.01%	1516
2019 Q1	$71K	Buy	93 +1	+1%	+$909	﹤0.01%	1595
2018 Q4	$89K	Buy	+92	New	+$121K	﹤0.01%	1483

Other funds holding ACET

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

ProShare Advisors's ACET Position: Q3 2021 in Review

ProShare Advisors sold out of Adicet Bio (ACET) in Q3 2021, closing a stake of 696 shares — an estimated $115K sold.

ProShare Advisors first reported a position in ACET in Q4 2018 and held it in 5 quarters. The position peaked at $115K in Q2 2021. 58 funds tracked by Wall St. Rank hold ACET as of Q3 2021.

ProShare Advisors reported no remaining Adicet Bio position as of Q3 2021 after selling out during the quarter.
ProShare Advisors sold 696 Adicet Bio shares in Q3 2021, an estimated $115K.
ProShare Advisors first reported a position in Adicet Bio in Q4 2018 and held it in 5 quarters.
ProShare Advisors's Adicet Bio position peaked at $115K in Q2 2021.
58 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2021.

Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.